{"id":"https://openalex.org/W2013862222","doi":"https://doi.org/10.1016/s1567-5688(05)80418-0","title":"W16-P-022 Study of the effect of atorvastatin on markers for prethrombotic state in patients with unstable angina and dyslipidaemia","display_name":"W16-P-022 Study of the effect of atorvastatin on markers for prethrombotic state in patients with unstable angina and dyslipidaemia","publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W2013862222","doi":"https://doi.org/10.1016/s1567-5688(05)80418-0","mag":"2013862222"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5688(05)80418-0","doi":"https://doi.org/10.1016/s1567-5688(05)80418-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(05)80418-0","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"N. Doncheva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Doncheva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041965591","display_name":"Z. Kuneva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z. Kuneva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018711142","display_name":"D. Zekleeva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Zekleeva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000988962","display_name":"L. Parvanova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Parvanova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"1","first_page":"106","last_page":"106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hypercoagulability","display_name":"hypercoagulability","score":0.9660000205039978},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.9860000014305115},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/meerwein-ponndorf-verley-reduction","display_name":"Meerwein-Ponndorf-Verley reduction","score":0.8519999980926514},{"id":"https://openalex.org/keywords/cinnamaldehyde","display_name":"cinnamaldehyde","score":0.906000018119812},{"id":"https://openalex.org/keywords/hydrotalcite","display_name":"hydrotalcite","score":0.800000011920929},{"id":"https://openalex.org/keywords/catalyst-recycling","display_name":"catalyst recycling","score":0.4880000054836273},{"id":"https://openalex.org/keywords/calcination","display_name":"calcination","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C2777435628","wikidata":"https://www.wikidata.org/wiki/Q204036","display_name":"Cinnamaldehyde","level":3,"score":0.8694764375686646},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.7545226812362671},{"id":"https://openalex.org/C7082614","wikidata":"https://www.wikidata.org/wiki/Q849523","display_name":"Calcination","level":3,"score":0.7479619979858398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7428216338157654},{"id":"https://openalex.org/C2780440420","wikidata":"https://www.wikidata.org/wiki/Q204030","display_name":"Cinnamyl alcohol","level":4,"score":0.6891595721244812},{"id":"https://openalex.org/C2778816286","wikidata":"https://www.wikidata.org/wiki/Q5192565","display_name":"Cue reactivity","level":4,"score":0.4908512234687805},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.38499975204467773},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.3433499336242676},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.24770155549049377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07185745239257812},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.0},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1567-5688(05)80418-0","doi":"https://doi.org/10.1016/s1567-5688(05)80418-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(05)80418-0","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2607417319","https://openalex.org/W2368631756","https://openalex.org/W2171915829","https://openalex.org/W1998181012","https://openalex.org/W1995032415","https://openalex.org/W2038195760","https://openalex.org/W2054087753","https://openalex.org/W2143837779","https://openalex.org/W2324034393","https://openalex.org/W3094585229"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}